Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2009 - 2011)

Updated

Kazia Therapeutics' Depreciation & Amortization - Total came in at $124,000 for fiscal Q2 2012 (quarter ended Dec 31, 2011), down 58.8% from $301,000 a year earlier.

Analysis

Kazia Therapeutics (KZIA) Depreciation & Amortization - Total (2009 - 2011) Analysis & Trends

For FY2009 (ended Aug 25, 2009), Kazia Therapeutics' Depreciation & Amortization - Total was $282,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 125,370.23
Dec 31, 2010 297,269.87
Dec 31, 2009 309,043.71
API Access

Kazia Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=KZIA&period=max&api_key=YOUR_API_KEY